Inve US ▾
AVAVAV

AeroVironment (AVAV) Q4 FY26 earnings call: guidance and Q&A

Earnings call· Apr 2026 (Q4 FY26)· Industrials· Jun 29, 2026

Source: earnings call transcript

Executive summary

AeroVironment Q4 FY26 — Record quarter as BlueHalo integration and organic strength drive scale

A transformational year closes with record scale as the BlueHalo combination and 30%-plus organic loitering-munition and counter-UAS demand offset a soft SCDE segment hit by the SCAR termination and government-shutdown drag. Management is deliberately trading near-term EPS and cash flow for aggressive capacity buildout, betting that a delayed but unprecedented FY27 defense-funding wave converts a deep backlog into multi-year growth.

Highlights

6
  • Record Q4 revenue of ~$642M with 31% organic growth YoY (30% pro forma) — the strongest quarterly growth rate of the year

  • Record full-year revenue of ~$2B with 30% organic growth and $2.7B of full-year bookings

  • Q4 adjusted EBITDA of $140M (22% of revenue), more than doubling from $62M in the prior-year quarter

  • Full-year adjusted EBITDA of $286M (14% margin), above the high end of revised guidance; non-GAAP EPS $3.31 vs $3.28 FY25

  • Titan RF counter-UAS sales more than doubled in FY26 (pro forma), making it one of the fastest-growing and most profitable product lines

  • First positive free-cash-flow quarter since Q1 FY25, at $73M

Concerns

7
  • Q4 book-to-bill fell to 0.9x (vs 1.4x trailing-12-month) on timing delays of anticipated large program awards

  • $89M incremental non-cash goodwill impairment (restated Q3 FY26) tied to SCAR termination, plus an identified material weakness in internal controls over the impairment analysis

  • SCDE segment revenue down 8% pro forma to $150M with negative $3M full-year adjusted EBITDA; Cyber & Mission Solutions down 26% pro forma

  • SCAR termination for convenience removed $1.5B of unfunded backlog and leaves a ~$30M revenue hole in Q1 FY27

  • Q4 adjusted service gross margin of just 2% from a one-time forward loss/EAC revision on a legacy BlueHalo contract and delayed CMS funding; full-year adjusted gross margin fell to 30% (from 40% in Q4 FY25)

  • FY27 free cash flow expected to be negative given elevated CapEx of 12-14% of revenue

  • Federal budget/CR timing uncertainty — guidance assumes FY27 funding does not arrive early, likely not reaching the services until ~March

Guidance & targets

CategoryTargetConfidence
Full-year revenue
$2.125B-$2.225B
high materiality
High
Adjusted EBITDA
$305M-$325M
high materiality
High
Non-GAAP adjusted EPS
$3.02-$3.34
high materiality
High
Depreciation and cloud amortization expense
increase ~$37M or ~77% YoY
medium materiality
Medium
Research and development expense (% of revenue)
7%-9% of revenue
medium materiality
High
Capital expenditures (% of revenue)
12%-14% of revenue
high materiality
High
Adjusted SG&A (% of revenue)
14%-16% of revenue
medium materiality
High
Free cash flow
Not expected to be positive in FY27
high materiality
Medium
Revenue phasing (H1 vs H2)
~45%-55% first half / second half split; Q1 = 45% of first-half revenue
medium materiality
Medium
Adjusted EBITDA phasing (H1 vs H2)
~1/3 first half / 2/3 second half; Q1 = 1/3 of first-half total
low materiality
Medium
Non-GAAP EPS phasing (H1 vs H2)
~25% first half / 75% second half; Q1 = 25% of first-half total
low materiality
Medium

Segment performance

SegmentRevenueYoYQoQMargin
Autonomous Systems (AxS)
Primary growth driver for the company; led by loitering munitions, RedDragon and Titan counter-UAS within Precision Strike.
Share of total revenue: 76% (Q4), 69% (FY26)Funded backlog: $869M (73% of total)Unfunded backlog: $209M (14% of total)
$492M (Q4); $1.3B (FY26)+49% vs FY25 pro forma (Q4)—FY26 adjusted EBITDA $289M (21% margin)
Precision Strike and Defense Systems (AxS operating group)
Fastest-growing operating group; also hit a one-time forward loss/EAC revision on a legacy BlueHalo contract in Q4.
Drivers: Switchblade loitering munitions, RedDragon one-way attack, Titan RF counter-UAS
$333M (Q4)+80% vs FY25 pro forma——
Uncrewed Aircraft Systems (AxS operating group)
Group 1-3 UAS group; won VAPOR 55 CLE (~$15M) and P550 LRR ($117M, just after quarter close) awards.
Drivers: JUMP 20-X, Puma, P550
—+17%——
Space, Cyber and Directed Energy (SCDE)
Pressured by the March SCAR termination for convenience and government-shutdown funding delays; negative FY adjusted EBITDA reflects under-absorption of fixed costs.
Funded backlog: $314M (27% of total)Unfunded backlog: $1.25B (86% of total, excludes $1.5B SCAR)SCAR-related revenue: $31M (Q4), $121M (FY26)
$150M (Q4); $619M (FY26)-8% pro forma (Q4)—FY26 adjusted EBITDA negative $3M
Space and Directed Energy (SCDE operating group)
Offset weakness in Cyber & Mission Solutions within the SCDE segment.
Driver: LOCUST directed-energy counter-UAS demand
—+23%——
Cyber and Mission Solutions (SCDE operating group)
On-site employee-deployment model hit by shutdown and DOGE-driven government service reductions; management expects only slow growth going forward.
Cause: discontinued programs and government-shutdown funding delays
—-26% pro forma——

AVAV operating KPIs by quarter

AVAV operating KPIs stated on its earnings calls, by fiscal quarter
KPI Jan 2026 Q3 FY26This call Apr 2026 Q4 FY26 Jul 2026 Q1 FY27Change vs prior quarter
Backlog Funded
$1.1B We ended the quarter with $1.1 billion of funded backlog and approximately $3 billion of unfunded backlog. Source: earnings call transcript
$1.2B Funded backlog closed at $1.2 billion, unfunded backlog at $1.5 billion, which now excludes SCAR contract values following the contract termination for convenience announced in March. Source: earnings call transcript
$1.5B Funding backlog totaled $1.5 billion at quarter end, which is 37% higher than the first quarter of fiscal year '26. Source: earnings call transcript
+25%
Backlog Unfunded
~$3B We ended the quarter with $1.1 billion of funded backlog and approximately $3 billion of unfunded backlog. Source: earnings call transcript
$1.5B Funded backlog closed at $1.2 billion, unfunded backlog at $1.5 billion, which now excludes SCAR contract values following the contract termination for convenience announced in March. Source: earnings call transcript
$1.4B Unfunded backlog at the end of the first quarter was $1.4 billion, was $1.2 billion or 89% attributable to the SCDE segment and $157 million or 11% to the AFS segment. Source: earnings call transcript
-6.7%
Funded backlog Autonomous Systems—
$869M Funded backlog totaled $1.2 billion at quarter end with $869 million or 73% attributable to the AxS segment and $314 million or 27% to the SCDE segment. Source: earnings call transcript
$1.1B Funding backlog composition by segment is $1.1 billion or 75% attributable to the AXS segment and $358 million or 25% to the [ FEEE ] segment. Source: earnings call transcript
+26.6%
Unfunded backlog Space, Cyber and Directed Energy—
$1.25B Unfunded backlog finished the year at $1.5 billion, which now excludes $1.5 billion related to the SCAR program with $1.25 billion or 86% attributable to SCDE and $209 million or 14% to AxS. Source: earnings call transcript
$1.2B Unfunded backlog at the end of the first quarter was $1.4 billion, was $1.2 billion or 89% attributable to the SCDE segment and $157 million or 11% to the AFS segment. Source: earnings call transcript
-4%
Unfunded backlog Autonomous Systems—
$209M Unfunded backlog finished the year at $1.5 billion, which now excludes $1.5 billion related to the SCAR program with $1.25 billion or 86% attributable to SCDE and $209 million or 14% to AxS. Source: earnings call transcript
$157M Unfunded backlog at the end of the first quarter was $1.4 billion, was $1.2 billion or 89% attributable to the SCDE segment and $157 million or 11% to the AFS segment. Source: earnings call transcript
-24.9%
Backlog —
$2.7B As we enter fiscal '27, we believe we have strong momentum across our product lines and a robust $2.7 billion of total backlog. Source: earnings call transcript
$2.8B+ Total funded and unfunded backlog at the end of the first quarter was just over $2.8 billion. Source: earnings call transcript
—
Orders —
$572M We secured bookings totaling $572 million in new authorized contract value. Source: earnings call transcript
$683M We secured bookings totaling $683 million in new authorized contract value. Source: earnings call transcript
+19.4%
Book-to-bill ratio —
0.9 ratio Our book-to-bill ratio for the quarter 4 was 0.9x, reflecting the exceptional quarter 4 revenue performance, partially offset by some timing delays of anticipated large program awards, while our trailing 12-month book-to-bill ratio stands at 1.4x. Source: earnings call transcript
1.4 ratio Our book-to-bill ratio for quarter 1 was 1.4x and reflecting strong demand from large program awards. Source: earnings call transcript
+55.6%

Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.

Orderbook & backlog

Total backlog $2.7B April 30, 2026 (FY26 year-end)

Comprises $1.2B funded and $1.5B unfunded; excludes IDIQ ceiling values.

Funded backlog $1.2B Q4 FY26 end

increased YoY

AxS $869M (73%); SCDE $314M (27%).

Unfunded backlog $1.5B FY26 year-end

now excludes $1.5B related to the terminated SCAR program

SCDE $1.25B (86%); AxS $209M (14%). Excludes ceiling values from sole-source IDIQ contracts including the remaining balance of the $990M U.S. Army Switchblade contract and the remaining $874M UAS/counter-UAS FMS contract.

Full-year bookings $2.7B (FY26); $572M in Q4 FY26 / Q4 FY26

Q4 book-to-bill 0.9x; trailing-12-month 1.4x

Q4 bookings in new authorized contract value; Q4 ratio pressured by timing delays of anticipated large program awards.

Product announcements

ProductTypeDetails
Switchblade 400launch
MAYHEM 10launch
RedDragonexpansion
LOCUST X3launch
HaloShieldroadmap
AV_Halo INSTINCT and AV_Halo DETECTlaunch
PANTHER (phased array next-generation telemetry hypersonic emitter receiver)milestone
Freedom Eagle 1 (FE1)milestone

Deals & partnerships

BlueHalo acquisition

Transformational acquisition completed ~a year ago; Titan RF counter-UAS (from BlueHalo) is among AV's fastest-growing and most profitable product lines; LOCUST directed energy also came with the deal. A one-time forward loss/EAC revision on a legacy BlueHalo contract hit Q4 following indirect-rate realignment.

ESAero acquisition

Smaller acquisition completed during FY26; contribution disclosed in response to an analyst question on FY27 organic growth.

Capital programs

Salt Lake City manufacturing facility (Switchblade / loitering munitions) underway
Period spend: part of FY27 CapEx (12-14% of revenue)
Funding: CapEx / cash (production-capacity growth CapEx)

Benefit:potential to produce more than $2B/year of Switchblades or other AV products

'Progress continues on our Salt Lake City manufacturing facility, which has the potential to produce more than $2 billion worth of Switchblades or other AV products per year. We're on track to begin production in the spring of calendar year 2027.'

Huntsville, Alabama facility expansion (Freedom Eagle 1) underway
Period spend: part of FY27 CapEx
Funding: CapEx / cash
Start: announced this past quarter

Benefit:scales production of the FE1 kinetic interceptor platform

'we announced efforts to expand our manufacturing facility in Huntsville, Alabama to scale production of this groundbreaking capability'; facility specifically targeted to produce the FE1 platform.

Albuquerque, New Mexico facility expansion (LOCUST directed energy) underway $30M
Period spend: part of FY27 CapEx
Funding: CapEx / cash
Start: recently announced

Benefit:significantly expands LOCUST laser weapon manufacturing capacity

'We recently announced a $30 million investment to significantly expand manufacturing operations in our Albuquerque, New Mexico facility.'

Dayton, Ohio production capacity expansion underway
Period spend: part of FY27 CapEx
Funding: CapEx / cash

Benefit:additional production capacity to support long-term revenue growth

Named alongside Salt Lake City, Huntsville and Albuquerque as multiple production-capacity sites being expanded in FY27.

Risks & headwinds

Federal budget / continuing-resolution timing delaying FY27 funding Government FY27 (starting October 2026) through early calendar 2027

Guidance assumes no early funding; budget likely passed ~December/January, dollars to services ~March; first-half revenue softer (45/55 split)

Mitigation:Living off strong existing backlog and already-approved funding; managing to full-year guidance; not assuming reconciliation-bill upside

SCAR program termination for convenience Announced March 2026; impact through FY27

Removed $1.5B of unfunded backlog; ~$30M revenue hole in Q1 FY27; $121M of FY26 SCAR revenue not recurring; drove $89M non-cash goodwill impairment

Mitigation:Excluded from FY27 guidance; portfolio diversification reduces single-program dependence

Goodwill impairment restatement and material weakness in internal controls Identified Q4 FY26; remediation requires multiple quarters of control testing

$89M incremental non-cash charge (Q3 FY26 restated); remaining SCDE goodwill $1.2B ($291M Space unit)

Mitigation:Enhanced controls and review procedures implemented and executed in Q4; error detected and corrected by management

Book-to-bill below 1.0 in the quarter Q4 FY26

Q4 book-to-bill 0.9x (vs 1.4x trailing-12-month)

Mitigation:Attributed to timing delays of anticipated large program awards; TTM ratio remains 1.4x

Cyber & Mission Solutions weakness FY26; slow recovery expected

Down 26% pro forma in Q4; contributed to SCDE negative $3M FY26 adjusted EBITDA

Mitigation:Market seen as stabilized; expected to grow slowly; not the highest-growth area of the portfolio

Low Q4 service gross margin from one-time charges Q4 FY26 (characterized as one-time)

Q4 adjusted service gross margin 2%; one-time forward loss/EAC revision on a legacy BlueHalo contract (dollar not disclosed) plus delayed CMS funding

Mitigation:Tied to indirect-rate realignment from integration; expected non-recurring; FY27 margins to improve on product/services mix

Negative free cash flow in FY27 FY27

FY27 FCF not expected to be positive; CapEx 12-14% of revenue

Mitigation:Investment is for production-capacity growth to support long-term revenue; Q4 FY26 already returned to positive FCF ($73M); streamlined Switchblade acceptance testing to shorten cash conversion cycle

Supply-chain and production-ramp execution across multiple scaling platforms FY27 and beyond

Not quantified; half a dozen products scaling significantly simultaneously

Mitigation:Expanding supplier base and throughput; management cites two decades of scaling track record as a competitive advantage

Reconciliation-bill timing uncertainty Potentially before midterms but likely delayed by election cycle

Up to $350B bill; not assumed in guidance; wide range of outcomes

Mitigation:Guidance conservative (excludes it); management would update if it materializes, expecting positive revenue and margin impact

Q&A highlights

How big is the counter-UAS business today and its growth profile, and how should we think about the remaining $1.2B goodwill and SCAR into FY27?

Wahid sized counter-UAS at ~$200M in FY26 (Titan doubled), described a three-layer strategy (Titan RF, LOCUST directed energy, FE1 kinetic) and predicted DE/counter-UAS could become 2-3x the size of the ~$0.5B loitering-munition business in 3-5 years. Sean explained the $89M impairment was a Q3 calculation error on acquired tax-attribute goodwill, not a cash-flow change, corrected in Q4, leaving $1.2B SCDE goodwill ($291M Space).

“It will not surprise me in the next 3 to 5 years that our directed energy and our counter UAS business would be equally as large, if not 2 to 3x bigger.”

asked by Sheila Kahyaoglu · answered by Wahid Nawabi

3 min read 6 chapters

Detailed narrative

Record Q4 and full-year results cap a transformational year

AV delivered record Q4 revenue of ~$642M (31% organic growth, its strongest quarterly rate of the year) and record full-year revenue of ~$2B (30% organic growth). Full-year bookings reached $2.7B and full-year adjusted EBITDA of $286M (14% margin) came in above the high end of revised guidance, with non-GAAP EPS of $3.31.

Q4 adjusted EBITDA of $140M (22% of revenue) more than doubled year over year, demonstrating profitability leverage at higher volume. Management framed FY26 as a milestone year built on the BlueHalo combination that nearly doubled the company's size.

Precision Strike loitering munitions lead growth

The Precision Strike and Defense Systems operating group grew 80% over FY25 pro forma to $333M in Q4, led by the Switchblade family, RedDragon one-way attack, and Titan RF counter-UAS. Switchblade 400 won a LASSO program award; MAYHEM 10 (a Launched Effects/common-launch-tube system carrying up to 10 lb lethal or non-lethal payloads) debuted; and RedDragon received a $17M Q4 production contract.

The $990M Army Switchblade IDIQ is roughly two-thirds to three-quarters fulfilled with government options to extend or raise the ceiling, and Switchblade 600 Block 1 is at historic production levels with capacity for several thousand units per year.

Counter-UAS layered strategy: Titan, LOCUST directed energy, Freedom Eagle 1

Management describes a multilayered counter-UAS approach worth ~$200M in FY26 today. RF detect-and-defeat Titan sales more than doubled YoY. LOCUST directed-energy (under $10/shot, 'unlimited magazine') hit milestones including a 100% intercept rate aboard USS George H.W. Bush and FAA clearance in May to operate in domestic airspace; LOCUST X3 launched and full-rate production is targeted this year.

Freedom Eagle 1 (FE1), a low-cost kinetic interceptor targeted at $100K-$150K per copy, won a $96M development contract last fall (long-range Kinetic Intercept) with Congress adding funds to accelerate; flight testing is ~12 months out and the opportunity is framed at close to $1B over several years.

Space, Cyber & Directed Energy pressured by SCAR and shutdown

The SCDE segment fell 8% pro forma to $150M in Q4 on the March SCAR termination for convenience and government-shutdown funding delays that hit Cyber & Mission Solutions (down 26% pro forma). Within the segment, Space and Directed Energy grew 23% YoY on LOCUST demand.

SCAR-related revenue was $31M in Q4 and $121M for FY26. Bright spots include a $240M long-haul laser communication terminal contract (awarded last fall), a $43M PANTHER telemetry award on DoW's SkyRange platforms, and $20M ceramic-materials and $25M human-performance research awards.

Management remains bullish on optical laser comms and phased-array technology as early-cycle, highly differentiated opportunities.

Goodwill impairment restatement and material weakness

AV disclosed an $89M incremental, non-cash goodwill impairment tied to the SCAR termination, restating Q3 FY26. It stemmed from an error by a third-party accounting firm in the Q3 impairment calculation (excluding an estimated allocation of goodwill associated with acquired tax attributes), detected and corrected by management in Q4.

It did not affect current assets/liabilities, revenue, operating cash flow, or non-GAAP measures. A material weakness in internal controls over the impairment analysis was identified; enhanced controls were implemented but require testing over additional quarters to remediate the SOX control.

Remaining SCDE goodwill is $1.2B, of which $291M is the Space business unit.

Aggressive capacity investment and FY27 funding-timing caution

FY27 guidance sets revenue at $2.125B-$2.225B (~10% growth) and adjusted EBITDA at $305M-$325M, with CapEx of 12-14% of revenue and R&D of 7-9% funding a broad production buildout (Salt Lake City, Huntsville, Albuquerque, Dayton). Free cash flow is expected to be negative for the year.

Guidance deliberately assumes FY27 government funding arrives late — management expects a continuing resolution, a budget passed around December/January, and dollars not reaching the services until ~March — plus an uncertain $350B reconciliation bill. Revenue and profit are back-half weighted (45/55 revenue split).

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.